About US
Contact us
-
Fifty years of propionic acid manufacturing at BASF· Versatile intermediate · Eco-efficient feed preservative A rather acidic success story started at BASF 50 years ago: in the summer of 1960, the company brought on stream the first large-scale2010/9/1
-
Work Standards on Sampling Test for Food Safety Supervision in Catering Services issuedIn order to strengthen the supervision over the food safety in catering services and standardize the work of sampling test, the State Food and Drug Administration recently issued the Work Standards on2010/9/1
-
Eisai receives new action date for FDA priority review of eribulin mesylate NDA for metastatic breast cancerEisai Inc. announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency expects to complete priority review of the eribulin mesylate New Drug Appl2010/8/31
-
Research on clopidogrel reports complexity to FDA black box warningNew findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix. After res2010/8/31
-
Ricerca Biosciences completes purification of an API under cGMP controlsRicerca Biosciences, a uniquely integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, is pleased to announce the successful completion of th2010/8/30
-
FDA approves Novartis' Tekamlo for treatment of high blood pressureThe US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin in2010/8/30
-
FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritisChelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced confirmation by the U.S. Food and Drug Administration (FDA) that its proposed Phase II protocol for CH-4051 in rheumatoid arthritis has2010/8/27
-
FDA notification confirms acyclovir Lauriad for oro-facial herpes labialisRegulatory News: “This notification from the FDA confirms that acyclovir Lauriad® represents an innovation in the treatment of oro-facial herpes labialis and strengthens our position to find the2010/8/27
-
FDA to Priority Review Bristol-Myers Squibb Melanoma DrugBristol-Myers Squibb has received confirmation that the US Food and Drug Administration (FDA) has accepted its biologics licence application for ipilimumab for filing and review. The company also an2010/8/26
-
Commissioner Shao Mingli meets Director of Singapore Health Sciences AuthorityOn August 17, 2010, Shao Mingli, commissioner of the State Food and Drug Administration, met the visiting Dr John Lim, Director of Singapore Health Sciences Authority and his party. Both parties discu2010/8/26